 Drug and Narcotic Control
"Drug and Narcotic Control" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Control of drug and narcotic use by international agreement, or by institutional systems for handling prescribed drugs. This includes regulations concerned with the manufacturing, dispensing, approval (DRUG APPROVAL), and marketing of drugs.
| Descriptor ID |
D004335
|
| MeSH Number(s) |
I01.880.604.605.250 N03.706.615.402.250 N04.452.706.310
|
| Concept/Terms |
Pharmaceutical Policy- Pharmaceutical Policy
- Pharmaceutical Policies
- Policies, Pharmaceutical
- Policy, Pharmaceutical
- Pharmaceutic Policy
Narcotic Control- Narcotic Control
- Control, Narcotic
- Controls, Narcotic
- Narcotic Controls
Drug Control- Drug Control
- Control, Drug
- Controls, Drug
- Drug Controls
Drug Regulations- Drug Regulations
- Drug Regulation
- Regulation, Drug
- Regulations, Drug
|
Below are MeSH descriptors whose meaning is more general than "Drug and Narcotic Control".
Below are MeSH descriptors whose meaning is more specific than "Drug and Narcotic Control".
This graph shows the total number of publications written about "Drug and Narcotic Control" by people in this website by year, and whether "Drug and Narcotic Control" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2003 | 1 | 0 | 1 | | 2007 | 0 | 1 | 1 | | 2013 | 1 | 0 | 1 | | 2014 | 1 | 1 | 2 | | 2017 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Drug and Narcotic Control" by people in Profiles.
-
Frank RG, Pollack HA. Addressing the Fentanyl Threat to Public Health. N Engl J Med. 2017 Feb 16; 376(7):605-607.
-
Pollack HA, Reuter P. Does tougher enforcement make drugs more expensive? Addiction. 2014 Dec; 109(12):1959-66.
-
Aronsohn A, Reau N, Jensen D. Preparing for the uncertain yet inevitable: off-label combinations of antiviral agents in hepatitis C virus. Hepatology. 2014 May; 59(5):1688-91.
-
Gunderson EW, Kirkpatrick MG, Willing LM, Holstege CP. Substituted cathinone products: a new trend in "bath salts" and other designer stimulant drug use. J Addict Med. 2013 May-Jun; 7(3):153-62.
-
Ehrenpreis ED, Kulkarni P, Burke C. What gastroenterologists should know about the gray market, herbal remedies, and compounded pharmaceuticals and their regulation by the Food and Drug Administration. Am J Gastroenterol. 2013 May; 108(5):642-6.
-
Ehrenpreis ED, Ciociola AA, Kulkarni PM. How the FDA manages drug safety with black box warnings, use restrictions, and drug removal, with attention to gastrointestinal medications. Am J Gastroenterol. 2012 Apr; 107(4):501-4.
-
Whitley RJ. The role of oseltamivir in the treatment and prevention of influenza in children. Expert Opin Drug Metab Toxicol. 2007 Oct; 3(5):755-67.
-
Zacny J, Bigelow G, Compton P, Foley K, Iguchi M, Sannerud C. College on Problems of Drug Dependence taskforce on prescription opioid non-medical use and abuse: position statement. Drug Alcohol Depend. 2003 Apr 01; 69(3):215-32.
-
Kombo LA, Gerber MA, Pickering LK, Atreya CD, Breiman RF. Intussusception, infection, and immunization: summary of a workshop on rotavirus. Pediatrics. 2001 Aug; 108(2):E37.
-
Demozay D, Vincent V. [Industrial secrecy and anti-poison centers]. Eur J Toxicol Hyg Environ. 1973 Nov-Dec; 6(6):266-74.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|